19933596

Source:http://linkedlifedata.com/resource/pubmed/id/19933596

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0015031, umls-concept:C0024143, umls-concept:C0034510, umls-concept:C0087111, umls-concept:C0268425, umls-concept:C0871261, umls-concept:C1704632, umls-concept:C1706817, umls-concept:C2603343, umls-concept:C2911692
pubmed:issue	1
pubmed:dateCreated	2009-12-9
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00377637
pubmed:abstractText	To compare the efficacy and safety of mycophenolate mofetil (MMF) and intravenous cyclophosphamide (IVC) as induction treatment for lupus nephritis (LN), by race, ethnicity and geographical region.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-10568907, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-11036121, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-11324784, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-11678445, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-11953977, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-11958584, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-12079714, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-12133539, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-12209517, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-12630753, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-13679478, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-14747370, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-14747764, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-14999109, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-15334435, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-15593207, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-15728784, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-1599520, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-16221103, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-16306519, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-16527882, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-16598205, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-16761508, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-16929249, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-17167111, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-18042591, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-19369404, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-8210301, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-8559480, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-8815753, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-9083285, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-9324032, http://linkedlifedata.com/resource/pubmed/commentcorrection/19933596-9663472
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100883501
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Mycophenolic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/mycophenolate mofetil
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1462-0332
pubmed:author	pubmed-author:AppelGerald BGB, pubmed-author:ContrerasGabrielG, pubmed-author:DooleyMary AMA, pubmed-author:GinzlerEllen MEM, pubmed-author:IsenbergDavidD, pubmed-author:JayneDavidD, pubmed-author:Sánchez-GuerreroJorgeJ, pubmed-author:SolomonsNeilN, pubmed-author:WofsyDavidD, pubmed-author:YuXueqingX
pubmed:issnType	Electronic
pubmed:volume	49
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	128-40
pubmed:meshHeading	pubmed-meshheading:19933596-Adolescent, pubmed-meshheading:19933596-Adult, pubmed-meshheading:19933596-Aged, pubmed-meshheading:19933596-Child, pubmed-meshheading:19933596-Cyclophosphamide, pubmed-meshheading:19933596-Drug Administration Schedule, pubmed-meshheading:19933596-Drug Therapy, Combination, pubmed-meshheading:19933596-Humans, pubmed-meshheading:19933596-Immunosuppressive Agents, pubmed-meshheading:19933596-Lupus Nephritis, pubmed-meshheading:19933596-Middle Aged, pubmed-meshheading:19933596-Mycophenolic Acid, pubmed-meshheading:19933596-Opportunistic Infections, pubmed-meshheading:19933596-Prednisone, pubmed-meshheading:19933596-Prospective Studies, pubmed-meshheading:19933596-Treatment Outcome, pubmed-meshheading:19933596-Young Adult
pubmed:year	2010
pubmed:articleTitle	Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study.
pubmed:affiliation	Centre for Rheumatology, University College London, London, UK.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study